Covered recipient · General Payments record
RAYGAN L LOFTON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,233.75
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $358.05 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $78.15 | 4 |
| ABBVIE INC. | $69.70 | 4 |
| Vertos Medical, Inc. | $55.99 | 1 |
| GlaxoSmithKline, LLC. | $51.13 | 3 |
| Novo Nordisk AS | $36.34 | 2 |
| Astellas Pharma US Inc | $20.59 | 1 |
| Amgen Inc. | $16.04 | 1 |
| DEXCOM, INC. | $15.56 | 1 |
| Lilly USA, LLC | $14.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.72 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884319 | CMS |
| ABBVIE INC. | $17.69 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884321 | CMS |
| ABBVIE INC. | $14.52 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884323 | CMS |
| ABBVIE INC. | $18.77 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884325 | CMS |
| Amgen Inc. | $16.04 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115879575 | CMS |
| Astellas Pharma US Inc | $20.59 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139412795 | CMS |
| Dexcom, Inc. | $15.56 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153329909 | CMS |
| GlaxoSmithKline, LLC. | $21.27 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116035120 | CMS |
| GlaxoSmithKline, LLC. | $15.34 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116574192 | CMS |
| GlaxoSmithKline, LLC. | $14.52 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116298556 | CMS |
| Lilly USA, LLC | $14.55 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135370976 | CMS |
| Novo Nordisk Inc | $17.81 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096901505 | CMS |
| Novo Nordisk Inc | $18.53 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096578195 | CMS |
| PFIZER INC. | $17.75 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131895040 | CMS |
| PFIZER INC. | $17.23 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132110961 | CMS |
| PFIZER INC. | $24.31 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131100748 | CMS |
| PFIZER INC. | $18.86 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131240203 | CMS |
| Vertos Medical, Inc. | $55.99 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133342865 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.